Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape.
Saved in:
| Title: | Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape. |
|---|---|
| Authors: | Soulen MC; Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; and michael.soulen@pennmedicine.upenn.edu., Rilling WS; Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 270-271. Date of Electronic Publication: 2024 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Comment |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
